NEW YORK (GenomeWeb) – PositiveID announced today that it has formed a new subsidiary called ExcitePCR for the purposes of fully developing its Firefly Dx real-time PCR breadboard prototype pathogen detection system.

ExcitePCR, which is wholly owned by PositiveID, will own Firefly Dx. This arrangement allows for greater strategic flexibility, enabling the company to better pursue development partnerships or financing opportunities, PositiveID said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.